Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+4,458,622
SEC-reported price per share
$6.99
Number of holders
18
Value change
+$31,087,038
Number of buys
14
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,393,481

Security key

08205P209

Report period

Q2 2024

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Steven Michael Oliveira
Disclosed value leader
Steven Michael Oliveira
Comparable rows
0/14
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $3,044,300 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

Steven Michael Oliveira has the largest disclosed position value at $3.04M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Steven Michael Oliveira's linked filing trail.
Disclosed position value Top 5
Steven Michael Oliveira $3.04M
FRANKLIN TEMPLETON INC $3.01M
Janus Henderson Group Ltd. $1.27M
MONTANOVA CAPITAL, LLC $1.07M
ADAGE CAPITAL PARTNERS GP, L.L.C. $993.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Steven Michael Oliveira
3/4/5
10%+ Owner
—
denominator unverified
$3,044,300
1,000,000 shares
— 28 Apr 2021
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$3,012,147
588,310 shares
— 31 Mar 2024
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$1,266,463
244,491 shares
— 31 Mar 2024
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$1,072,155
204,220 shares
— 31 Mar 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$993,237
189,188 shares
— 31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$87,680
16,701 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
5,729,459
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q2 2026 Across Filers

Q2 2026 holders
86
Q2 2024 holders
18
Holder diff
-68
Investor Q2 2026 Shares Q2 2024 Shares Share Diff Share Chg % Q2 2026 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .